limestone has been researched along with Osteoporosis, Postmenopausal in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.00) | 18.7374 |
1990's | 18 (36.00) | 18.2507 |
2000's | 16 (32.00) | 29.6817 |
2010's | 14 (28.00) | 24.3611 |
2020's | 1 (2.00) | 2.80 |
Authors | Studies |
---|---|
Chin, KY; Ekeuku, SO; Ima-Nirwana, S; Noor, MMM; Qian, J; Qu, H; Ramli, ESM; Wang, Y; Wong, SK | 1 |
Barnea, Z; Biro, A; Cernes, R; Katzir, Z; Zandman-Goddard, G | 1 |
Mazokopakis, EE | 1 |
Ayyoub, S; Coyne, C | 1 |
Geng, D; Guo, X; Liu, Y; Xu, Y; Yang, H; Zhou, W | 1 |
Anastasilakis, AD; Chatzifotiadis, D; Kokkoris, P; Makras, P; Papatheodorou, A; Polyzos, SA | 1 |
Basile, G; Brancatelli, S; Catalano, A; Cucinotta, D; Lasco, A; Morabito, N | 1 |
Aati, O; Bristow, SM; Gamble, GD; Horne, AM; Horne, L; House, ME; Mihov, B; Reid, IR; Stewart, A | 1 |
Bristow, SM; Gamble, GD; Horne, AM; Reid, IR; Stewart, A | 1 |
Li, H; Wang, SX | 1 |
Lachcik, PJ; Legette, LL; Martin, BR; Shahnazari, M; Weaver, CM; Welch, J | 1 |
Heaney, RP; Lappe, JM; Recker, RR; Watson, P | 1 |
Basso, U; Berton, L; Brunello, A; Coin, A; Falci, C; Manzato, E; Monfardini, S; Perissinotto, E; Pintore, G; Sergi, G; Veronese, N | 1 |
Abrams, SA; Fujii, Y; Fujita, T; Hirai, M; Ishida, H; Kaji, H; Kakumoto, M; Ohue, M; Uenishi, K | 1 |
Burkhalter, F; Dickenmann, M; Forster, C | 1 |
Anderson, GL; Cauley, JA; Chlebowski, RT; Datta, M; Jackson, RD; Lacroix, AZ; LeBlanc, ES; Manson, JE; Pettinger, MB; Prentice, RL; Rossouw, JE; Van Horn, L; Vitolins, MZ; Wactawski-Wende, J | 1 |
Jiang, Y; Li, M; Meng, X; Tian, J; Xia, W; Xing, X; Yu, W; Zhou, X | 1 |
Petrova, I | 1 |
Fujii, Y; Fujita, T; Miyauchi, A; Ohue, M; Takagi, Y | 1 |
Istok, R; Masaryk, P; Rovenský, J; Stancíková, M; Svík, K | 1 |
Benevolenskaia, LI; Dzeranova, LK; Evstigneeva, LP; Grudinina, OV; Korotkova, TA; Kuznetsov, SIu; Lesniak, OM; Marova, EI; Men'shikova, LV; Molitvoslovova, NN; Nikitinskaia, OA; Rozhinskaia, LIa; Sharapova, EP; Shestakova, IG; Smetnik, VP; Toroptsova, NV | 1 |
Eastell, R; Ingle, BM; Machado, AB; Pereda, CA | 1 |
Bilezikian, JP; Black, DM; Ensrud, KE; Greenspan, SL; Hue, T; Lang, TF; McGowan, JA; Palermo, L; Rosen, CJ | 1 |
Bianchi, G; Brandi, ML; Caudarella, R; D'Erasmo, E; Fiore, C; Isaia, GC; Luisetto, G; Muratore, M; Nuti, R; Oriente, P; Ortolani, S | 1 |
Bell, NH; Bröll, J; Dequeker, J; Downs, RW; Favus, M; Liberman, UA; Minne, HW; Quan, H; Rodriguez-Portales, J; Weiss, SR | 1 |
Ringe, JD | 1 |
Brizendine, E; Dunipace, A; Farley, S; Jackson, R; Katz, B; Kelly, S; Li, Y; Noblitt, T; Stookey, G; Zhang, W | 1 |
Aloia, JF; Flaster, E; Russo, L; Sheehan, M; Vaswani, A | 1 |
Harris, ST | 1 |
Carrière, EG; Koopmans, PP; Lekkerkerker, JF; van Bronswijk, H | 1 |
Loeliger, EA | 1 |
Aloia, JF; Dilmanian, FA; Flaster, E; Ross, PL; Vaswani, A; Yeh, JK | 1 |
Forbes, RB; Grant, DJ; MacWalter, RS | 1 |
Collette, J; Giacovelli, G; Gosset, C; Meurmans, L; Minne, HW; Reginster, JY; Rovati, LC; Setnikar, I; Taquet, AN; Zegels, B | 1 |
Miura, T; Nakano, M | 1 |
Braga de Castro Machado, A; Eastell, R; Hannon, R | 1 |
Castelo-Branco, C; Pons, F; Sanjuán, A; Vanrell, JA; Vicente, JJ | 1 |
Kashyap, AS; Kashyap, S | 1 |
Chan, YH; Griffith, J; Lau, EM; Woo, J | 1 |
Albert, A; Lejeune, E; Micheletti, MC; Reginster, JY; Taquet, AN; Zegels, B | 1 |
Bendich, A; Bierman, J; Dowell, MS; Hale, CA; Heaney, RP | 1 |
Chansirikarn, S; Domrongkitchaiporn, S; Ongphiphadhanakul, B; Puavilai, G; Rajatanavin, R; Stitchantrakul, W | 1 |
Hofstede, GJ; Muskiet, FA; Pakan, I; Schaafsma, A; van der Veer, E; van Doormaal, JJ | 1 |
Bardin, C; Brouard, A; Kuntz, D; Lioté, F; Liou, A; Terrier, JL | 1 |
Aloia, JF; McGowan, DM; Ross, P; Vaswani, A; Yeh, JK | 1 |
Pak, CY; Sakhaee, K | 1 |
Horowitz, M; Morris, HA; Need, AG; Nordin, BE | 1 |
Baylink, DJ; Gallagher, JC; Genant, HK; Harris, ST; Herber, M; Steiger, P | 1 |
Díaz López, C; Farrerons, J; López Ciudad, A; Olazabal, A; Rams, A | 1 |
1 review(s) available for limestone and Osteoporosis, Postmenopausal
Article | Year |
---|---|
Eggshell calcium in the prevention and treatment of osteoporosis.
Topics: Animals; Biological Availability; Biological Factors; Calcium Carbonate; Chickens; Clinical Trials as Topic; Dietary Supplements; Egg Shell; Female; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Powders | 2003 |
30 trial(s) available for limestone and Osteoporosis, Postmenopausal
Article | Year |
---|---|
Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Calcitriol; Calcium Carbonate; Drug Therapy, Combination; Female; Follow-Up Studies; Hip Prosthesis; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postoperative Care; Single-Blind Method; Zoledronic Acid | 2019 |
Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis.
Topics: Aged; Antibodies, Monoclonal, Humanized; Bone Density; Calcium; Calcium Carbonate; Cholecalciferol; Denosumab; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Prospective Studies; Time Factors; Treatment Outcome; Vitamins | 2013 |
Zoledronic acid acutely increases sclerostin serum levels in women with postmenopausal osteoporosis.
Topics: Adaptor Proteins, Signal Transducing; Aged; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Bone Regeneration; Bone Resorption; Calcium Carbonate; Cholecalciferol; Collagen Type I; Combined Modality Therapy; Dietary Supplements; Diphosphonates; Female; Genetic Markers; Humans; Imidazoles; Infusions, Intravenous; Middle Aged; Osteoporosis, Postmenopausal; PAX5 Transcription Factor; Peptides; Time Factors; Zoledronic Acid | 2013 |
Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women.
Topics: Aged; Biomarkers; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Calcium; Calcium Carbonate; Calcium Citrate; Calcium Phosphates; Calcium, Dietary; Collagen Type I; Dietary Supplements; Durapatite; Female; Humans; Osteoporosis, Postmenopausal; Peptides; Phosphates; Postmenopause | 2014 |
Acute effects of calcium supplements on blood pressure and blood coagulation: secondary analysis of a randomised controlled trial in post-menopausal women.
Topics: Aged; Aged, 80 and over; Blood Coagulation; Blood Coagulation Disorders; Blood Pressure; Bone Density Conservation Agents; Calcium Carbonate; Calcium Citrate; Calcium, Dietary; Cohort Studies; Dietary Supplements; Double-Blind Method; Durapatite; Elder Nutritional Physiological Phenomena; Female; Humans; Hypertension; Middle Aged; New Zealand; Osteoporosis, Postmenopausal; Patient Dropouts; Risk | 2015 |
Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
Topics: Adult; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Calcitonin; Calcium; Calcium Carbonate; Drug Administration Schedule; Female; Femur Neck; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2008 |
Phosphate and carbonate salts of calcium support robust bone building in osteoporosis.
Topics: Administration, Oral; Aged; Body Mass Index; Bone Density; Bone Development; Calcium; Calcium Carbonate; Calcium Phosphates; Cholecalciferol; Female; Humans; Injections, Subcutaneous; Middle Aged; Osteoporosis, Postmenopausal; Patient Selection; Single-Blind Method; Tablets | 2010 |
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.
Topics: Aged; Bone Density Conservation Agents; Calcium Carbonate; Cardiovascular Diseases; Cholecalciferol; Dietary Supplements; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Hip Fractures; Humans; Middle Aged; Neoplasms; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Risk Assessment; United States; Urinary Calculi | 2013 |
[Alendronate in postmenopausal women with osteopenia and osteoporosis: effects on bone mineral density during treatment and after withdrawal].
Topics: Aged; Alendronate; Alkaline Phosphatase; Bone Density; Bone Diseases, Metabolic; Calcium Carbonate; Double-Blind Method; Female; Follow-Up Studies; Hip Joint; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Time Factors; Treatment Outcome | 2002 |
Reappraisal of Katsuragi calcium study, a prospective, double-blind, placebo-controlled study of the effect of active absorbable algal calcium (AAACa) on vertebral deformity and fracture.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Body Weight; Bone and Bones; Bone Density; Calcium; Calcium Carbonate; Data Interpretation, Statistical; Double-Blind Method; Eukaryota; Female; Fractures, Spontaneous; Humans; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Prospective Studies; Radiography; Spinal Fractures; Spine; Treatment Outcome | 2004 |
[Vitrum osteomag in prevention of osteoporosis in postmenopausal women: results of the comparative open multicenter trial].
Topics: Absorptiometry, Photon; Aged; Bone Density; Calcium; Calcium Carbonate; Cholecalciferol; Dietary Supplements; Female; Femur; Humans; Lumbar Vertebrae; Magnesium; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Trace Elements | 2004 |
Monitoring alendronate and estradiol therapy with quantitative ultrasound and bone mineral density.
Topics: Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Calcium Carbonate; Double-Blind Method; Drug Implants; Estradiol; Female; Femur Neck; Finger Phalanges; Follow-Up Studies; Humans; Hysterectomy; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Radiography; Severity of Illness Index; Treatment Outcome; Ultrasonography | 2005 |
One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.
Topics: Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Remodeling; Calcium Carbonate; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Treatment Outcome; Vitamin D | 2005 |
Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Calcium Carbonate; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Vitamin D | 2006 |
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
Topics: Aged; Aged, 80 and over; Alendronate; Body Height; Bone Density; Calcium Carbonate; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Incidence; Middle Aged; Osteoporosis, Postmenopausal; Spinal Fractures; Spine | 1995 |
The effect of fluoride therapy on blood chemistry parameters in osteoporotic females.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Analysis of Variance; Bilirubin; Blood Chemical Analysis; Bone and Bones; Calcium Carbonate; Chlorides; Drug Therapy, Combination; Female; Fluorides; gamma-Glutamyltransferase; Humans; L-Lactate Dehydrogenase; Liver; Lymphocytes; Middle Aged; Osteoporosis, Postmenopausal; Serum Albumin; Serum Globulins; Sister Chromatid Exchange; Sodium; Water | 1994 |
The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass.
Topics: Adipose Tissue; Aging; Body Composition; Body Mass Index; Calcium Carbonate; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal | 1995 |
Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss.
Topics: Analysis of Variance; Bone Density; Calcium Carbonate; Calcium, Dietary; Combined Modality Therapy; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Progesterone | 1994 |
The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.
Topics: Aged; Analysis of Variance; Bone Density; Calcium Carbonate; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Fluorides; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Radiography; Spinal Fractures; Thoracic Vertebrae | 1998 |
Monitoring alendronate therapy for osteoporosis.
Topics: Aged; Alendronate; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Remodeling; Bone Resorption; Calcium Carbonate; Collagen; Collagen Type I; Female; Humans; Middle Aged; Osteocalcin; Osteogenesis; Osteoporosis, Postmenopausal; Peptides | 1999 |
Preventing postmenopausal bone loss with ossein-hydroxyapatite compounds. Results of a two-year, prospective trial.
Topics: Aged; Bone Density; Calcium Carbonate; Durapatite; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Treatment Outcome | 1999 |
Alendronate prevents bone loss in Chinese women with osteoporosis.
Topics: Aged; Alendronate; Bone Density; Calcium Carbonate; China; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Placebos | 2000 |
Influence of daily calcium and vitamin D supplementation on parathyroid hormone secretion.
Topics: Adolescent; Adult; Calcium; Calcium Carbonate; Cross-Over Studies; Dietary Supplements; Drug Administration Schedule; Humans; Male; Osteoporosis, Postmenopausal; Parathyroid Hormone; Reference Values; Time Factors; Vitamin D | 2001 |
Absorbability and cost effectiveness in calcium supplementation.
Topics: Area Under Curve; Biological Availability; Calcium; Calcium Carbonate; Calcium Citrate; Calcium, Dietary; Cost-Benefit Analysis; Cross-Over Studies; Dietary Supplements; Female; Fractures, Bone; Humans; Intestinal Absorption; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause | 2001 |
Risk of calcium oxalate nephrolithiasis in postmenopausal women supplemented with calcium or combined calcium and estrogen.
Topics: Aged; Calcium Carbonate; Calcium Oxalate; Dietary Supplements; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Kidney Calculi; Medrogestone; Middle Aged; Osteoporosis, Postmenopausal; Risk Assessment | 2002 |
Positive effects of a chicken eggshell powder-enriched vitamin-mineral supplement on femoral neck bone mineral density in healthy late post-menopausal Dutch women.
Topics: Age Factors; Aged; Animals; Biomarkers; Bone Density; Calcium; Calcium Carbonate; Chickens; Dietary Supplements; Double-Blind Method; Drug Combinations; Egg Shell; Female; Femur Neck; Humans; Middle Aged; Osteoporosis, Postmenopausal; Patient Compliance; Postmenopause; Trace Elements; Vitamins | 2002 |
Bioavailability of fluoride in postmenopausal women: comparative study between sodium fluoride and disodium monofluorophosphate-calcium carbonate.
Topics: Aged; Biological Availability; Calcium Carbonate; Drug Combinations; Drug Evaluation; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Patient Compliance; Sodium Fluoride; Tablets, Enteric-Coated | 1992 |
Biochemical short-term changes produced by hormonal replacement therapy.
Topics: Bone Remodeling; Calcitonin; Calcitriol; Calcium; Calcium Carbonate; Estrogen Replacement Therapy; Female; Humans; Hydroxyproline; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone | 1991 |
Effects of three different calcium preparations on urinary calcium and hydroxyproline excretion in postmenopausal osteoporotic women.
Topics: Absorption; Aged; Biological Availability; Calcium Carbonate; Circadian Rhythm; Creatinine; Fasting; Female; Humans; Hydroxyproline; Osteoporosis, Postmenopausal; Solubility | 1991 |
Effect of estrone sulfate on postmenopausal bone loss.
Topics: Bone Density; Calcium Carbonate; Cholesterol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal | 1990 |
19 other study(ies) available for limestone and Osteoporosis, Postmenopausal
Article | Year |
---|---|
Normalisation of High Bone Remodelling due to Oestrogen Deficiency by Traditional Chinese Formulation
Topics: Animals; Bone Density; Bone Resorption; Calcium Carbonate; China; Estrogens; Female; Humans; Laos; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Sprague-Dawley; Water | 2022 |
Severe Hypocalcemia Following a Single Denosumab Injection.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Calcium Carbonate; Denosumab; Female; Humans; Hydroxycholecalciferols; Hypocalcemia; Osteoporosis, Postmenopausal; RANK Ligand; Renal Insufficiency, Chronic; Treatment Outcome; Vitamin D Deficiency | 2017 |
Denosumab-induced Normocalcemic Hyperparathyroidism in a Woman with Postmenopausal Osteoporosis and Normal Renal Function.
Topics: Bone Density Conservation Agents; Calcium; Calcium Carbonate; Cholecalciferol; Denosumab; Female; Humans; Hyperparathyroidism; Kidney Function Tests; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone | 2018 |
VISUAL VIGNETTE.
Topics: Alendronate; Bone Density Conservation Agents; Calcium Carbonate; Female; Femoral Fractures; Humans; Middle Aged; Osteoporosis, Postmenopausal; Vitamin D | 2018 |
[Study indites calcium as a heart breaker. 30 % more myocardial infarcts caused by high dosage calcium preparations].
Topics: Bone Density; Calcium Carbonate; Calcium Citrate; Dietary Supplements; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Magnesium; Middle Aged; Myocardial Infarction; Nutritional Requirements; Osteoporosis, Postmenopausal; Potassium Citrate; Vitamin D | 2013 |
Diet calcium level but not calcium supplement particle size affects bone density and mechanical properties in ovariectomized rats.
Topics: Animals; Body Weight; Bone and Bones; Bone Density; Calcium; Calcium Carbonate; Calcium, Dietary; Dietary Supplements; Disease Models, Animal; Female; Humans; Osteoporosis, Postmenopausal; Ovariectomy; Particle Size; Rats; Weight Gain | 2009 |
Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer.
Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Bone Resorption; Breast Neoplasms; Calcium Carbonate; Cohort Studies; Combined Modality Therapy; Dietary Supplements; Etidronic Acid; Female; Follow-Up Studies; Humans; Neoplasm Staging; Nitriles; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Risedronic Acid; Severity of Illness Index; Triazoles; Vitamin D | 2012 |
Fractional absorption of active absorbable algal calcium (AAACa) and calcium carbonate measured by a dual stable-isotope method.
Topics: Absorption; Aged; Animal Shells; Animals; Biological Availability; Calcium; Calcium Carbonate; Calcium Chloride; Calcium Isotopes; Calcium, Dietary; Female; Humans; Japan; Middle Aged; Osteoporosis, Postmenopausal; Ostreidae; Seaweed | 2010 |
Hypoventilation: a risk factor for milk alkali syndrome?
Topics: Aged; Analgesics, Opioid; Back Pain; Calcium Carbonate; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Hypoventilation; Infusion Pumps; Injections, Spinal; Long-Term Care; Morphine; Osteoporosis, Postmenopausal; Risk Factors; Sodium Chloride Symporter Inhibitors | 2010 |
[Osteobor forte--rational solution in fight against osteoporosis].
Topics: Bone Density; Boron Compounds; Calcium Carbonate; Drug Combinations; Female; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Vitamin D | 2003 |
[Calcium carbonate intake: a possibility for long term osteoporosis prevention?].
Topics: Calcium Carbonate; Female; Humans; Male; Osteoporosis, Postmenopausal | 1995 |
[Didrokit (etidronic acid-calcium carbonate) in the treatment of postmenopausal osteoporosis improperly recorded?].
Topics: Calcium Carbonate; Drug Combinations; Etidronic Acid; Female; Humans; Osteoporosis, Postmenopausal | 1994 |
[Didrokit (etidronic acid-calcium carbonate) for the treatment of postmenopausal osteoporosis improperly recorded?].
Topics: Calcium Carbonate; Drug Combinations; Etidronic Acid; Female; Humans; Netherlands; Osteoporosis, Postmenopausal; Registries | 1994 |
[Didrokit (etidronic acid-calcium carbonate) for the treatment of postmenopausal osteoporosis recorded improperly?].
Topics: Aged; Calcium Carbonate; Drug Combinations; Etidronic Acid; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal | 1994 |
Cyclical etidronate and calcium carbonate (with citrate) supplementation for osteoporosis unmasking primary hyperparathyroidism.
Topics: Aged; Aged, 80 and over; Antacids; Calcium; Calcium Carbonate; Citrates; Citric Acid; Diagnosis, Differential; Etidronic Acid; Female; Humans; Hyperparathyroidism; Osteoporosis, Postmenopausal | 1995 |
Calcium bioavailability of a total bone extract (TBE) and its effects on bone metabolism in rats.
Topics: Animals; Biological Availability; Biomarkers; Bone Density; Calcium; Calcium Carbonate; Citric Acid; Female; Femur; Humans; Intestinal Absorption; Lactic Acid; Magnesium; Male; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorus; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Tissue Extracts | 1998 |
Hypoparathyroidism unmasked by alendronate.
Topics: Aged; Alendronate; Calcitriol; Calcium Carbonate; Calcium Channel Agonists; Female; Humans; Hypocalcemia; Hypoparathyroidism; Osteoporosis, Postmenopausal | 2000 |
Fluoride bioavailability from immediate-release sodium fluoride with calcium carbonate compared with slow-release sodium fluoride with calcium citrate.
Topics: Aged; Biological Availability; Calcium Carbonate; Citrates; Citric Acid; Delayed-Action Preparations; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Sodium Fluoride | 1991 |
[An analysis of calcium pidolate absorption and a comparison with that of a salt in common use, gluconate-lactate-carbonate, in postmenopausal osteoporosis].
Topics: Absorption; Aged; Calcium; Calcium Carbonate; Calcium Gluconate; Drug Combinations; Drug Evaluation; Drug Tolerance; Female; Humans; Lactates; Lactic Acid; Middle Aged; Osteoporosis, Postmenopausal; Pyrrolidonecarboxylic Acid | 1989 |